01 8MAYNE PHARMA
01 88715724
01 8Blank
01 8Y
01 82028-02-03
Patent Expiration Date : 2028-02-03
US Patent Number : 8715724
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50795
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-03
Patent Expiration Date : 2028-02-03
US Patent Number : 8715724
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50795
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-03
Patent Expiration Date : 2028-02-03
US Patent Number : 8715724
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50795
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-03
Patent Expiration Date : 2028-02-03
US Patent Number : 8715724
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50795
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-03
Patent Expiration Date : 2028-02-03
US Patent Number : 8715724
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50795
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-03
Patent Expiration Date : 2028-02-03
US Patent Number : 8715724
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50795
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-03
Patent Expiration Date : 2028-02-03
US Patent Number : 8715724
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50795
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-03
Patent Expiration Date : 2028-02-03
US Patent Number : 8715724
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 50795
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-02-03
